WO2008145620A1 - Process for the deprotection of aryl group protected amines employing oxidases - Google Patents
Process for the deprotection of aryl group protected amines employing oxidases Download PDFInfo
- Publication number
- WO2008145620A1 WO2008145620A1 PCT/EP2008/056389 EP2008056389W WO2008145620A1 WO 2008145620 A1 WO2008145620 A1 WO 2008145620A1 EP 2008056389 W EP2008056389 W EP 2008056389W WO 2008145620 A1 WO2008145620 A1 WO 2008145620A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- enzyme
- substituted
- process according
- group
- deprotection
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 86
- 230000008569 process Effects 0.000 title claims abstract description 79
- 150000001412 amines Chemical class 0.000 title claims abstract description 54
- 238000010511 deprotection reaction Methods 0.000 title claims abstract description 50
- 125000003118 aryl group Chemical group 0.000 title claims description 14
- 108090000854 Oxidoreductases Proteins 0.000 title description 2
- 102000004316 Oxidoreductases Human genes 0.000 title description 2
- 108090000790 Enzymes Proteins 0.000 claims abstract description 72
- 102000004190 Enzymes Human genes 0.000 claims abstract description 72
- -1 amine compound Chemical class 0.000 claims abstract description 40
- 230000001590 oxidative effect Effects 0.000 claims abstract description 37
- 239000007800 oxidant agent Substances 0.000 claims abstract description 29
- 125000006239 protecting group Chemical group 0.000 claims abstract description 17
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 5
- 238000011065 in-situ storage Methods 0.000 claims abstract description 3
- 150000003335 secondary amines Chemical class 0.000 claims abstract description 3
- 108010029541 Laccase Proteins 0.000 claims description 50
- 229910001868 water Inorganic materials 0.000 claims description 17
- 239000000758 substrate Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 10
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 9
- 125000003342 alkenyl group Chemical group 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 125000000304 alkynyl group Chemical group 0.000 claims description 9
- 125000005002 aryl methyl group Chemical group 0.000 claims description 9
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 5
- 125000003107 substituted aryl group Chemical group 0.000 claims description 5
- 150000003857 carboxamides Chemical class 0.000 claims description 4
- 150000001733 carboxylic acid esters Chemical class 0.000 claims description 4
- 125000002843 carboxylic acid group Chemical group 0.000 claims description 4
- 150000007970 thio esters Chemical class 0.000 claims description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 62
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 54
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 45
- 238000006243 chemical reaction Methods 0.000 description 37
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 32
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- 239000000243 solution Substances 0.000 description 25
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 24
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 24
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 23
- 239000000203 mixture Substances 0.000 description 22
- 235000019439 ethyl acetate Nutrition 0.000 description 21
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 15
- 239000001301 oxygen Substances 0.000 description 15
- 229910052760 oxygen Inorganic materials 0.000 description 15
- 239000011541 reaction mixture Substances 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 12
- 239000006184 cosolvent Substances 0.000 description 12
- 229940093499 ethyl acetate Drugs 0.000 description 12
- 239000008363 phosphate buffer Substances 0.000 description 12
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 10
- 238000005160 1H NMR spectroscopy Methods 0.000 description 10
- 239000007832 Na2SO4 Substances 0.000 description 10
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 229910052938 sodium sulfate Inorganic materials 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 125000001424 substituent group Chemical group 0.000 description 9
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 8
- 125000003545 alkoxy group Chemical group 0.000 description 8
- IMNFDUFMRHMDMM-UHFFFAOYSA-N anhydrous n-heptane Natural products CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 7
- 125000004122 cyclic group Chemical group 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- AKGGYBADQZYZPD-UHFFFAOYSA-N benzylacetone Chemical compound CC(=O)CCC1=CC=CC=C1 AKGGYBADQZYZPD-UHFFFAOYSA-N 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 150000000179 1,2-aminoalcohols Chemical group 0.000 description 5
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 5
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- LGZDNJBUAAXEMN-UHFFFAOYSA-N 1,2,2,3-tetramethyl-1-oxidopiperidin-1-ium Chemical compound CC1CCC[N+](C)([O-])C1(C)C LGZDNJBUAAXEMN-UHFFFAOYSA-N 0.000 description 4
- GZXUZTBBDWZZGV-UHFFFAOYSA-N 2-(4-phenylbutan-2-ylamino)phenol;hydrochloride Chemical compound Cl.C=1C=CC=C(O)C=1NC(C)CCC1=CC=CC=C1 GZXUZTBBDWZZGV-UHFFFAOYSA-N 0.000 description 4
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 4
- KGHUMABDRADJLS-UHFFFAOYSA-N 2-methoxy-n-(4-phenylbutan-2-yl)aniline Chemical compound COC1=CC=CC=C1NC(C)CCC1=CC=CC=C1 KGHUMABDRADJLS-UHFFFAOYSA-N 0.000 description 4
- ULNIGNODVQAGAB-UHFFFAOYSA-N 4-(4-phenylbutan-2-ylamino)phenol Chemical compound C=1C=C(O)C=CC=1NC(C)CCC1=CC=CC=C1 ULNIGNODVQAGAB-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000009849 deactivation Effects 0.000 description 4
- 238000003818 flash chromatography Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 238000007086 side reaction Methods 0.000 description 4
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000725101 Clea Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 239000005864 Sulphur Substances 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 229940126543 compound 14 Drugs 0.000 description 3
- 239000012847 fine chemical Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000012047 saturated solution Substances 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- JVNDYNGFAMKWSY-NINOIYOQSA-N (2s,3s)-2-methyl-3-(methylamino)-3-(4-nitrophenyl)propan-1-ol;hydrochloride Chemical compound Cl.OC[C@@H](C)[C@H](NC)C1=CC=C([N+]([O-])=O)C=C1 JVNDYNGFAMKWSY-NINOIYOQSA-N 0.000 description 2
- AYXBXACAUHZOKK-ACJLOTCBSA-N (2s,3s)-3-(4-methoxy-n-methylanilino)-2-methyl-3-(4-nitrophenyl)propan-1-ol Chemical compound C1=CC(OC)=CC=C1N(C)[C@@H]([C@H](C)CO)C1=CC=C([N+]([O-])=O)C=C1 AYXBXACAUHZOKK-ACJLOTCBSA-N 0.000 description 2
- SEZANEIDXMUDFW-YNDBEVAQSA-N (2s,3s)-3-(4-methoxyanilino)-2-methyl-3-phenylpropan-1-ol;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1N[C@@H]([C@H](C)CO)C1=CC=CC=C1 SEZANEIDXMUDFW-YNDBEVAQSA-N 0.000 description 2
- NTAUHAXHFPDEDI-QJVKKXMWSA-N (2s,3s)-3-amino-2-methyl-3-(4-nitrophenyl)propan-1-ol;hydrochloride Chemical compound Cl.OC[C@@H](C)[C@H](N)C1=CC=C([N+]([O-])=O)C=C1 NTAUHAXHFPDEDI-QJVKKXMWSA-N 0.000 description 2
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- YEHGSOZIZRABBU-UHFFFAOYSA-N 1-phenylethanamine;hydrochloride Chemical compound [Cl-].CC([NH3+])C1=CC=CC=C1 YEHGSOZIZRABBU-UHFFFAOYSA-N 0.000 description 2
- HRRVLSKRYVIEPR-UHFFFAOYSA-N 6-hydroxy-5-nitroso-1H-pyrimidine-2,4-dione Chemical compound OC1=NC(O)=C(N=O)C(O)=N1 HRRVLSKRYVIEPR-UHFFFAOYSA-N 0.000 description 2
- 241000222519 Agaricus bisporus Species 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 238000010268 HPLC based assay Methods 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 238000006683 Mannich reaction Methods 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 241000222355 Trametes versicolor Species 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 230000002051 biphasic effect Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 229940125961 compound 24 Drugs 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 150000002466 imines Chemical class 0.000 description 2
- 239000008176 lyophilized powder Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- GMJUGPZVHVVVCG-UHFFFAOYSA-N n-hydroxy-n-phenylacetamide Chemical compound CC(=O)N(O)C1=CC=CC=C1 GMJUGPZVHVVVCG-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- GCUPLRINQHVUDX-UHFFFAOYSA-N phenyl 2-iodoacetate Chemical compound ICC(=O)OC1=CC=CC=C1 GCUPLRINQHVUDX-UHFFFAOYSA-N 0.000 description 2
- 239000003495 polar organic solvent Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000006268 reductive amination reaction Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- WJUFSDZVCOTFON-UHFFFAOYSA-N veratraldehyde Chemical compound COC1=CC=C(C=O)C=C1OC WJUFSDZVCOTFON-UHFFFAOYSA-N 0.000 description 2
- WXLGBPILVNJZTN-ISRZGASSSA-N (2s)-4-amino-4-(3,4-dimethoxyphenyl)butan-2-ol;hydrochloride Chemical compound Cl.COC1=CC=C(C(N)C[C@H](C)O)C=C1OC WXLGBPILVNJZTN-ISRZGASSSA-N 0.000 description 1
- WXCAUJZIRFHZGD-RUINGEJQSA-N (4s)-4-(3,4-dimethoxyphenyl)-4-(4-methoxyanilino)butan-2-ol Chemical compound C1=CC(OC)=CC=C1N[C@@H](CC(C)O)C1=CC=C(OC)C(OC)=C1 WXCAUJZIRFHZGD-RUINGEJQSA-N 0.000 description 1
- JSIJVMBVUBWSNO-KRWDZBQOSA-N (4s)-4-(3,4-dimethoxyphenyl)-4-(4-methoxyanilino)butan-2-one Chemical compound C1=CC(OC)=CC=C1N[C@@H](CC(C)=O)C1=CC=C(OC)C(OC)=C1 JSIJVMBVUBWSNO-KRWDZBQOSA-N 0.000 description 1
- 0 *[C@]([C@@](CO)N)c(cc1)ccc1[N+]([O-])=O Chemical compound *[C@]([C@@](CO)N)c(cc1)ccc1[N+]([O-])=O 0.000 description 1
- MOHYOXXOKFQHDC-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCl)C=C1 MOHYOXXOKFQHDC-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- HQFLTUZKIRYQSP-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole-6-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2N(CC)CSC2=C1 HQFLTUZKIRYQSP-UHFFFAOYSA-N 0.000 description 1
- LVQSUJANKVLTKT-UHFFFAOYSA-N 4-phenylbutan-2-ylazanium;chloride Chemical compound Cl.CC(N)CCC1=CC=CC=C1 LVQSUJANKVLTKT-UHFFFAOYSA-N 0.000 description 1
- 125000005915 C6-C14 aryl group Chemical group 0.000 description 1
- KCBAMQOKOLXLOX-BSZYMOERSA-N CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O Chemical compound CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O KCBAMQOKOLXLOX-BSZYMOERSA-N 0.000 description 1
- ATHBASHTAAIHNE-UHFFFAOYSA-N CCCCc(c(-c(cc(cc1)OC)c1N)c1OC)ccc1OC Chemical compound CCCCc(c(-c(cc(cc1)OC)c1N)c1OC)ccc1OC ATHBASHTAAIHNE-UHFFFAOYSA-N 0.000 description 1
- HPZCJIATWYACHF-IAGOWNOFSA-N COc1ccc(CN[C@@H]([C@@H](CO)N)c(cc2)ccc2[N+]([O-])=O)cc1 Chemical compound COc1ccc(CN[C@@H]([C@@H](CO)N)c(cc2)ccc2[N+]([O-])=O)cc1 HPZCJIATWYACHF-IAGOWNOFSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- 102000043368 Multicopper oxidase Human genes 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 125000001743 benzylic group Chemical group 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940126208 compound 22 Drugs 0.000 description 1
- 229940125833 compound 23 Drugs 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000006345 epimerization reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 108700020788 multicopper oxidase Proteins 0.000 description 1
- VQSRKMNBWMHJKY-YTEVENLXSA-N n-[3-[(4ar,7as)-2-amino-6-(5-fluoropyrimidin-2-yl)-4,4a,5,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-methoxypyrazine-2-carboxamide Chemical compound C1=NC(OC)=CN=C1C(=O)NC1=CC=C(F)C([C@@]23[C@@H](CN(C2)C=2N=CC(F)=CN=2)CSC(N)=N3)=C1 VQSRKMNBWMHJKY-YTEVENLXSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- VMPITZXILSNTON-UHFFFAOYSA-N o-anisidine Chemical compound COC1=CC=CC=C1N VMPITZXILSNTON-UHFFFAOYSA-N 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 108020001775 protein parts Proteins 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000011916 stereoselective reduction Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- KCDXJAYRVLXPFO-UHFFFAOYSA-N syringaldehyde Chemical compound COC1=CC(C=O)=CC(OC)=C1O KCDXJAYRVLXPFO-UHFFFAOYSA-N 0.000 description 1
- COBXDAOIDYGHGK-UHFFFAOYSA-N syringaldehyde Natural products COC1=CC=C(C=O)C(OC)=C1O COBXDAOIDYGHGK-UHFFFAOYSA-N 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- MHYGQXWCZAYSLJ-UHFFFAOYSA-N tert-butyl-chloro-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](Cl)(C(C)(C)C)C1=CC=CC=C1 MHYGQXWCZAYSLJ-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical group 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
Definitions
- the invention relates to a process for the deprotection of protected amines and the use of oxidative enzymes in a process for the deprotection of protected 5 amines.
- Protecting groups in particular the para-methoxyphenyl (PMP) group, are increasingly used as a nitrogen protecting group for amines, in particular secondary and tertiary amines.
- PMP para-methoxyphenyl
- the PMP protecting group appeared to be a crucial element for reaching high 10 enantioselectivities, as has been described in for example M. M. B. Marques, Angew. Chem. 2006, 118, 356-360.
- industrial application of the PMP-protecting group has been thwarted by a lack of cheap and practical deprotection methods.
- eerie ammonium nitrate (CAN) has been used for deprotection, which is expensive and highly toxic.
- the present invention aims at providing a further alternative for the deprotection of protected amine compounds.
- oxidative enzymes may be used 25 to effect deprotection of protected amine compounds.
- the invention relates to a process for the deprotection of protected amines, wherein the protected amine compound is contacted with an oxidative enzyme and an oxidising agent.
- deprotection may be carried out under mild conditions. Mild conditions are for example ambient temperature, or temperatures not much higher than 40°C, or aqueous solutions, or conditions which allow reactions in the absence of strong acids or strong bases. It is an advantage of the process according to the invention that when protected amine compounds having one or more chiral centres at the ⁇ - and/or ⁇ carbon atom of 35 the amine are deprotected, the deprotection may be carried out under conditions mild enough not to cause racemisation or epimerization of the chiral centre(s) .
- the amino group of the protected amine compound is preferably protected by an optionally substituted aryl or arylmethyl group, most preferably by an optionally substituted C 6 - C 14 aryl or arylmethyl group.
- optionally substituted aryl or arylmethyl groups include optionally substituted phenyl, naphthyl and benzyl groups.
- it is preferred that such aryl or arylmethyl groups are activated by electron-donating groups, wherein the aryl or arylmethyl group is preferably substituted at positions that maximise the activating effect of the electron-donating substituent.
- substitution patterns are well known to the person skilled in the art and include for example the ortho- and para-positions of a phenyl ring.
- the amino group of the protected amine compound is protected with a phenyl or benzyl group that is substituted with an electron-donating substituent, wherein the phenyl or benzyl group is substituted at an ortho-position and/or the para-position.
- the phenyl or benzyl group may be substituted with more than one electron-donating substituents, wherein the electron-donating substituent may be the same or different.
- the phenyl or benzyl group may be substituted with two substituents wherein one substituent is at the para-position and the other at the ortho- position.
- An electron-donating group is herein defined as a group that releases electrons into a reaction center and as such stabilizes electron deficient carbocatjons.
- the electron-donating group has a Hammett ⁇ p -constant of less than -0.14.
- the values for ⁇ p are taken from J. March, Advanced Organic Chemistry, 4 th Ed., page 280 (Table 9.4), 1992.
- Preferred electron-donating groups include linear or branched Ci - C 6 alkyl groups, cyclic C 3 - C 6 alkyl groups, linear or branched Ci - C 6 alkoxy groups, cyclic C 3 - C 6 alkoxy groups, linear or branched Ci - C 6 alkylthio groups, cyclic C 3 - C 6 alkylthio groups and OH. More preferred electron-donating groups are linear or branched Ci - C 6 alkyl groups, cyclic C 3 - C 6 alkyl groups, linear or branched Ci - C 6 alkoxy groups and cyclic C 3 - C 6 alkoxy groups.
- Even more preferred electron-donating groups are linear or branched Ci - C 6 alkoxy groups and cyclic C 3 - C 6 alkoxy groups. Yet even more preferred electron-donating groups are linear or branched Ci - C 6 alkoxy groups, even yet more preferably linear or branched C 1 - C 4 alkoxy groups. Most preferably, the electron- donating group is methoxy. If the phenyl or benzyl group has more than one substituent, their combined electron-donating capability is preferably equivalent to a Hammett ⁇ p -constant of less than -0.14. It is well known to the person skilled in the art which combinations of substituents provide such an electron-donating capability.
- Preferred protecting groups are ortho-methoxyphenyl, para- methoxyphenyl (PMP), ortho-hydroxyphenyl, para-hydroxyphenyl and para- methoxybenzyl.
- the most preferred protecting group is the p-methoxyphenyl-group.
- the protected amine may be derived from the protecting of any N-atoms for which protection is known. Typically, the N-atom of a secondary or tertiary amine group is protected, and may now be deprotected by the process according to the invention. Conversion of protected imines may result in protected amines, that may also be deprotected by a process according to the invention.
- deprotection is defined as removing the protecting group from the N-atom.
- the process according to the invention may be suitably applied to effect deprotection of any protected amine compound.
- Preferred compounds to be deprotected by the process according to the invention are for example compounds according to formula 1.
- R 4 H, or a (substituted) alkyl, (substituted) cycloalkyl, (substituted) alkenyl, (substituted) alkynyl or (substituted) aryl group
- R 1 , R 2 and R 3 are each independently H or (substituted) alkyl, (substituted) cycloalkyl, (substituted) alkenyl, (substituted) alkynyl or (substituted) aryl groups or carboxylic acid groups or salts thereof, carboxylic esters, carboxylic thioesters or carboxamides. provided that at least two out of R 1 , R 2 and R 3 are not H and provided that not more than two groups chosen from R 1 , R 2 and R 3 are carboxylic acid groups or salts thereof, carboxylic esters, carboxylic thioesters or carboxamides.
- R 4 can also be a protecting group, which is the same or different from the PG group. In case R 4 is the same PG then the removal of that group may take place simultaneously with the removal of the PG-group. Upon deprotection, a compound according to formula I is obtained, but with the one or two protecting groups replaced by H-atoms.
- R 2 and R 4 are as defined above in formula 1 and R 5 is H or a (substituted) alkyl, (substituted) cycloalkyl, (substituted) alkenyl, (substituted) alkynyl or (substituted) aryl group.
- These side reactions may be partially or fully avoided by first protecting the OH-group at the ⁇ -position, then performing the amine deprotection with an oxidative enzyme of the present invention, and finally removing the OH-protecting group.
- the OH-group can be protected with a benzyl group, using benzylbromide and sodium hydride, followed by amine deprotection with a laccase enzyme - with limited or no side reactions due to cleavage of the C-C bond of the 1 ,2-amino-alcohol moiety - and finally removal of the benzyl group using hydrogenation with hydrogen and Pd/C under acidic conditions, giving the desired deprotected 1 ,2-amino-alcohol in high yield.
- the OH-group can, for example, also be protected with a tert-butyl-diphenylsilyl group, using tert-butyl-diphenylsilylchloride in the presence of imidazole, followed by amine deprotection with a laccase enzyme - with limited or no side reactions due to cleavage of the C-C bond of the 1 ,2-amino- alcohol moiety - and finally removal of the tert-butyl-diphenylsilyl group by HF/pyridine, giving the desired deprotected 1 ,2-amino-alcohol in high yield.
- the method according to the invention is carried out with a protected amine compound not comprising an OH-gropu at the ⁇ -position.
- the cycloalkyl groups in protected amines according to formula 1 or 2 may optionally have one or more unsaturated, exocyclic or endocyclic, carbon carbon bonds.
- the alkyl, cycloalkyl, alkenyl, alkynyl, and aryl groups that may be present in protected amines according to formula 1 or 2 may be substituted with optionally protected, functional groups comprising one or more heteroatoms such as for example oxygen, sulphur and nitrogen.
- the alkyl, alkenyl and alkynyl groups may be interrupted by one or more heteroatoms such as oxygen, sulphur and nitrogen, whereas the cycloalkyl and aryl groups may comprise within their ring system one or more heteroatoms such as oxygen, sulphur and nitrogen.
- the alkyl, alkenyl, and alkynyl groups that may be present in R 1 , R 2 , R 3 , R 4 and R 5 each independently typically comprise 1-30 C atoms.
- at least one of R 1 , R 2 , R 3 ' R 4 and R 5 comprises 1-6 C atoms, more preferably, all R 1 , R 2 , R 3 , R 4 and R 5 comprise between 1-6 C atoms if they are an alkyl, alkenyl or alkynyl group.
- the cycloalkyl or aryl group that may be present in R 1 , R 2 , R 3 ,R 4 and R 5 typically comprises 1-30 C atoms.
- at least one of R 1 , R 2 , R 3 ,R 4 and R 5 comprises 3-6 C atoms, more preferably, all R 1 , R 2 , R 3 R 4 and R 5 comprise between 3- 6 C atoms if they are a cycloalkyl or aryl group.
- an oxidative enzyme is defined as an enzyme which catalyses an oxidation reaction of a substrate, in this case the substrate being the compound to be deprotected, in the presence of an oxidant.
- the enzyme used in the process according to the invention must be able to catalyse oxidations, more preferably, it is able to catalyse one electron oxidations.
- An enzyme suitable for the process according to the invention typically comprises a protein part and one or more metal atoms, whereby the metal atom or atoms must be able to exist in at least two different oxidation states.
- the enzyme used in the process according to the invention is an oxidative enzyme chosen from enzyme class (E. C.) 1.10.3 or an oxidative enzyme of the enzyme class E. C. 1.1 1.
- laccases (E. C. 1.10.3.2) are used in the process according to the invention. Even more preferably, laccases are used for the removal of an optionally substituted aryl or optionally substituted arylmethyl protecting group. Most preferably, laccases are used for the removal of a PMP-protecting group.
- Laccases are multi-copper oxidases found in several trees and fungi, catalyzing the oxidation of various types of substances with concomitant reduction of oxygen to water, avoiding the formation of the hazardous hydrogen peroxide. Laccases are commercially available from e.g. J ⁇ lich Fine Chemicals and Sigma-Aldrich.
- a mixture of enzymes may also be used in the process according to the invention.
- the enzyme or enzymes used in the process according to the invention may be used in any form known, for example a such, as part of whole cells, or in immobilized form, for example as beads, etc.
- the process according to the invention is carried out in the presence of an oxidising agent, also sometimes referred to as oxidant.
- an oxidising agent also sometimes referred to as oxidant.
- any oxidising agent that is capable of oxidizing the protected amine may be used in the process according to the invention.
- oxidative enzyme needs a suitable oxidant.
- Suitable oxidants for a particular enzyme are known to the skilled person, and can be found e.g. through the Enzyme Classification system.
- oxygen is a suitable oxidant.
- the oxygen used in the process according to the invention is the oxygen dissolved in the reaction mixture.
- it is also possible to create a higher concentration of oxygen in the reaction mixture by contacting the reaction mixture with a gas containing oxygen in a higher concentration than air, or even with pure oxygen, for example by bubbling an oxygen containing gas or pure oxygen through the reaction mixture.
- peroxides for example
- H 2 O 2 may be suitably added as the oxidant.
- the process according to the invention also relates to a process for the deprotection of protected amine compounds according to the invention wherein the oxidant is formed in situ.
- the preparation of protected amines is known to a person skilled in the art.
- the protected amine compounds can, for instance, be prepared through reductive amination of the corresponding ketones with p-anisidine as, for example, described by A. Pelter, R. Rosser, S. Mills, J. Chem. Soc, Perkin Trans. 1 1984, 4,
- the protected amine compounds can be prepared via asymmetric Mannich reactions as, for instance, described by B. List et al, Angew.
- the process is carried out in a solution that comprises water. More preferably, at least one equivalent of water is present relative to the amine compound to be deprotected.
- the process according to the invention is carried out in a mixture of solvents, typically a mixture of water and one or more other solvents, also referred to as co-solvents. Any solvent may be used as a co-solvent.
- the co-solvent may have a miscibility with water that ranges from immiscible to poorly miscible to well miscible. Accordingly, the process according to the invention may be carried out as a one phase process or as a two or more phase process. It is known that enzymes may be deactivated by organic solvents.
- the process according to the invention is preferably carried out in the presence of water and a co-solvent that results in no or little deactivation during reaction.
- the process according to the invention is carried out in the presence of water and a solvent that together with water forms a homogeneous mixture. More preferably, the process is carried out in a mixture of water and a polar organic solvent, such as for example dimethylsulfoxide, methanol, acetonitrile, sulfolane, N,N-dimethylformamide, N-methyl-pyrrolidinone.
- a polar organic solvent such as for example dimethylsulfoxide, methanol, acetonitrile, sulfolane, N,N-dimethylformamide, N-methyl-pyrrolidinone.
- the polar organic solvent may be protic or aprotic.
- the amount of co-solvent may vary between wide ranges. Depending on the protected amine compound to be deprotected in the process according to the invention, it may be advantageous to increase the amount of protected amine compound that may be dissolved by increasing the amount of co-solvent. However, for solvents that cause deactivation of the enzyme used, it is preferred to use as little as possible. Therefore, the preferred amount of co-solvent depends on the protected amine compound used and the enzyme used. Typically, the amount of co-solvent used is more than 5 vol%, and typically the amount of co-solvent used is less than 50 vol%, relative to the total volume of the reaction mixture.
- the optimum pH for a process according to the invention can be determined by routine experimentation by a person skilled in the art.
- the pH may vary between wide limits, for example between 0 and 1 1.
- the optimum pH is lower than 9, preferably lower than 7, more preferably, lower than 6.
- the optimum pH is higher than 2, more preferably, higher than 2.5.
- a buffer may be used.
- the buffer is inert with respect to the compound to be deprotected and the (free) amine obtained after deprotection has taken place, the enzyme and the oxidant used.
- inert is defined as not reactive towards the reactant and desired product under the conditions under which the process according to the invention is carried out.
- buffer systems suitable for use in enzymatic reactions are phosphate buffers, acetate buffers and citric acid buffers. Depending on the desired pH and the type of enzyme used, a skilled person can select the most suitable buffer system.
- the pressure at which the process according to the invention may be carried out is not critical and may vary between wide limits, for example 0.01 bar and 100 bar.
- the process according to the invention is carried out under atmospheric pressure. Th e temperature at which the process according to the invention may be carried out is not critical, as long as it is not so high that the enzyme is deactivated. Typically, the process according to the invention is carried out at a temperature of 0°C or higher, preferably at a temperature of 10°C or higher, more preferably at a temperature of 15 °C or higher, even more preferably at a temperature of 20°C or higher, and most preferably at a temperature of 25°C or higher.
- the process according to the invention is typically carried out at a temperature of 80°C or lower, preferably 70°C or lower, more preferably 60°C or lower, even more preferably 50°C or lower, and most preferably 40°C or lower.
- the amount of enzyme relative to the protected amine compound is not critical, and will be different for each enzyme.
- the amount of enzyme added is based on a compromise between enzyme cost and reaction time. Many factors influence the activity of an enzyme, for example temperature, pH, type of solvent etc, thus, and hence, the amount added will also be influenced by those factors.
- a person skilled I the art will be able to determine for each enzyme which amounts are effective amounts, i.e. which amounts result in the desired conversion under the chosen reaction conditions.
- the suitable amount of oxidant relative to the protected amine compound can easily be determined by a person skilled in the art. For instance, if oxygen is used as the oxidant typically a large excess of oxidant is used for instance by contacting the reaction mixture with air or another gas containing oxygen. If hydrogen peroxide is used as the oxidant, the amount of oxidant is typically higher than 0.8 equivalent and preferably higher than 0.9 equivalent relative to the protected amine compound since full or almost full deprotection of the protected amine compound is usually desirable. If hydrogen peroxide is used as the oxidant, the amount of oxidant is also typically lower than 3 equivalent and preferably lower than 1.5 equivalent relative to the protected amine since a too high concentration of hydrogen peroxide may deactivate the enzyme.
- the process according to the invention is carried out in the presence of a mediator.
- a mediator is defined as an organic molecule acting as electron shuttle between the enzyme and the substrate.
- the use of a mediator may result in an improved conversion and/or selectivity relative to the same process according to the invention carried out in the absence of a mediator.
- Use of a mediator may also result in expanding the substrate scope of a given enzyme. In some cases, the enzymatic activity of a certain enzyme towards a certain protected amine compound only becomes easily detectable in the presence of a mediator.
- the mediator is oxidized by the enzyme (e.g. laccase) and then converts the substrate into the oxidized form.
- the reduced mediator can subsequently be reoxidized by the enzyme so that both the enzyme and the mediator can be used in a catalytic fashion using e.g. oxygen as the stoichiometric oxidant (thereby producing water as the by-product).
- the presence of a mediator in the process according to the invention results in a higher conversion in a shorter time than when the same reaction is carried out in the absence of a mediator. Moreover, it is shown that mediators often result in widening the substrate scope of a particular enzyme.
- the substrates are the protected amine compounds.
- mediators may be used in the process according to the invention.
- mediators can be found in literature on enzymes.
- Suitable mediators for the process according to the invention are for example compounds comprising an N-hydroxy functional group, and other mediators known for laccases.
- mediators for laccases are 2,2'- azinobis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS), violuric acid (VLA), 1 ,5- tetramethylpiperidine-N-oxide (TEMPO), hydroxybenzatriazole (HOBT), and syringaldehyde, as depicted in Figure 1 , and N-hydroxyacetanilide (NHA).
- ABTS 2,2'- azinobis(3-ethylbenzothiazoline-6-sulfonic acid
- VLA violuric acid
- TEMPO 1 ,5- tetramethylpiperidine-N-oxide
- HOBT hydroxybenzatriazole
- NHA N-hydroxyacetanilide
- the suitable amount of mediator may vary between wide limits, for example 0.001 - 10 molar equivalents relative to the protected amine compound.
- the mediator typically only needs relatively small quantities to be effective. Therefore, when a mediator is used, the process of the invention is preferably carried out in the presence of 0.01-0.2 molar equivalents of mediator relative to the protected amine compound.
- the invention also relates to a process for the deprotection of protected amines resulting from all possible combinations of claim 1 with one or more preferred embodiments, preferred protected amines, preferred reaction conditions, including preferred enzymes, oxidising agents or mediators, hitherto not explicitly disclosed as a combination.
- the invention also relates to the use of an oxidative enzyme for the deprotection of a protected amine compound as claimed in Claim 15, also in all possible combinations of one or more preferred features for the enzyme, the protected amine compound, the oxidising agent and any other applicable preferred feartures as disclosed herein.
- the resulting deprotected amines can be used as a pharmaceutical, nutraceutical, food or feed ingedrient or agrochemical or as an intermediate in the process thereto.
- the resulting deprotected amines can be converted to heterocyclic compounds.
- IR spectra were recorded on a Thermo Mattson IR300 equipped with a Harrick split pea ATR unit. 1 H NMR and 13 C NMR spectra were recorded at 300 (75) or 400 (100) MHz. HRMS (ESI) spectra were recorded on a JEOL AccuTOF. Commercially available laccase T from Trametes versicolor was purchased from J ⁇ lich Fine Chemicals in two batches as a light brown lyophilized powder. The activity of the first batch (used in the experiments as shown in Table 1 , entries 1-32) was 24 U/mg (using syringaldazin).
- the activity of the second batch was 1.2 U/mg (using syringaldazin).
- Laccase AB from Agaricus bisporus was commercially available from J ⁇ lich Fine Chemicals as a brown lyophilized powder (activity 7.9 U/mg (using catechol)).
- Amine 12 is commercially available.
- Amines 10 and 13 were prepared through reductive amination of the corresponding ketones as described in A. Pelter, R. Rosser, S. Mills, J. Chem. Soc, Perkin Trans. 1 1984, 4, 717-20.
- Amines 1 and 14 were prepared according to known procedures as described in Y. Hayashi, W. Tsuboi, I.
- the combined fractions were concentrated in vacuo and the residue was taken up in 50 mL n-heptane and extracted with 4 x 100 mL 1 M aqueous hydrochloric acid.
- the combined aqueous layers were brought to pH 12 using a 5 M aqueous potassium hydroxide solution and extracted with 3 x 100 mL dichloromethane.
- the combined organic layers were dried (Na 2 SO 4 ) and concentrated in vacuo, yielding the desired product 22 as a colorless oil (2.2 g, 8.6 mmol, 26% yield).
- the resulting aqueous phase was brought to pH 1 1 with a 5 M aqueous solution of potassium hydroxide and extracted with 3 x 75 ml. ethylacetate (while maintaining the pH at 11 by the addition of extra potassium hydroxide solution).
- the combined organic phase was dried (Na 2 SO 4 ), acidified with hydrochloric acid in ethylacetate and concentrated.
- the resulting residue was a mixture of the starting material and the desired deprotected amine as their HCI salts.
- the corrected yield for the product is 0.028 g (0.133 mmol, 75%).
- HPLC HPLC was conducted on an lnertsil ODS 3 column (150 mm length, 4.6 mm internal diameter) at a flow of 1.0 mL/min and using a UV detector at 210 and 254 nm.
- the eluent consisted of mixtures of solvent A (aqueous 10 mM phosphate buffer pH 3.0) and solvent B (acetonitrile).
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
In organic synthesis, amine functionalities are often protected by a protecting group. The invention relates to a process for the deprotection of a protected amine compound, wherein the protect ed amine compound which comprises a protecting group attached to the N-atom of the amine, is contacted with an oxidative enzyme and an oxidising agent that may optionally be formed in situ. The invention also relates to the use of oxidative enzymes in a process for deprotection of a protected amine compound, in particular protected secondary or tertiary amine compounds.
Description
PROCESS FOR THE DEPROTECTION OF ARYL GROUP PROTECTED AMINES EMPLOYING OXIDASES
The invention relates to a process for the deprotection of protected amines and the use of oxidative enzymes in a process for the deprotection of protected 5 amines.
Protecting groups, in particular the para-methoxyphenyl (PMP) group, are increasingly used as a nitrogen protecting group for amines, in particular secondary and tertiary amines. In particular in proline-catalyzed asymmetric Mannich reactions, the PMP protecting group appeared to be a crucial element for reaching high 10 enantioselectivities, as has been described in for example M. M. B. Marques, Angew. Chem. 2006, 118, 356-360. Until recently, industrial application of the PMP-protecting group has been thwarted by a lack of cheap and practical deprotection methods. In most cases, eerie ammonium nitrate (CAN) has been used for deprotection, which is expensive and highly toxic. In for example Janey et al, J. Org. Chem. 2006, 71, 15 390-392, phenyl iodoacetate has been described as an alternative for CAN. Another chemical alternative for the deprotection has been disclosed by Verkade et al, Tetrahedron Lett.2006, 47, 8109-8113, comprising the use of electrophilic halogen- containing oxidants for PMP-deprotection. Another alternative for deprotection has been disclosed by De Lamo Marin et al, J. Org. Chem. 2005, 70, 10592-10595, 20 wherein electrochemical deprotection has been proposed. However, known approaches do not provide viable alternatives for industrial application.
Thus, the present invention aims at providing a further alternative for the deprotection of protected amine compounds.
Surprisingly, it has been found that oxidative enzymes may be used 25 to effect deprotection of protected amine compounds.
Therefore, the invention relates to a process for the deprotection of protected amines, wherein the protected amine compound is contacted with an oxidative enzyme and an oxidising agent.
It is an advantage of the process according to the invention that the
30 deprotection may be carried out under mild conditions. Mild conditions are for example ambient temperature, or temperatures not much higher than 40°C, or aqueous solutions, or conditions which allow reactions in the absence of strong acids or strong bases. It is an advantage of the process according to the invention that when protected amine compounds having one or more chiral centres at the α- and/or β carbon atom of 35 the amine are deprotected, the deprotection may be carried out under conditions mild
enough not to cause racemisation or epimerization of the chiral centre(s) . It also is an advantage of the process according to the invention that no stoichiometric amounts of relatively expensive oxidants such as CAN, phenyl iodoacetate and halogen containing oxidants need to be used. In particular, the para-methoxybenzyl (PMB) group is increasingly used as a nitrogen protecting group for amines. PMB deprotection from amines can usually only be done by hydrogenation using a Pd containing catalyst (see also T.W. Greene and P. G. M. Wuts in "Protective groups in organic synthesis", 3rd edition, Wiley, 1999 page 581 ). These conditions also cause deprotection of N-benzyl protected amines so that the PMB group can not be selectively deprotected from an amine in the presence of an N-benzyl protected amine in the same molecule. Thus, it is an advantage of the process according to the invention that it allows deprotection of N- PMB protected amines leaving N-benzyl protection that may be present in the same molecule or in another molecule present during the deprotection fo the PMB-protected amine intact.
According to the invention, the amino group of the protected amine compound is preferably protected by an optionally substituted aryl or arylmethyl group, most preferably by an optionally substituted C6 - C14 aryl or arylmethyl group. Suitable examples of such optionally substituted aryl or arylmethyl groups include optionally substituted phenyl, naphthyl and benzyl groups. Additionally, it is preferred that such aryl or arylmethyl groups are activated by electron-donating groups, wherein the aryl or arylmethyl group is preferably substituted at positions that maximise the activating effect of the electron-donating substituent. Such substitution patterns are well known to the person skilled in the art and include for example the ortho- and para-positions of a phenyl ring. Consequently, it is preferred according to the invention that the amino group of the protected amine compound is protected with a phenyl or benzyl group that is substituted with an electron-donating substituent, wherein the phenyl or benzyl group is substituted at an ortho-position and/or the para-position. Obviously, the phenyl or benzyl group may be substituted with more than one electron-donating substituents, wherein the electron-donating substituent may be the same or different. In case of more than one substituent the phenyl or benzyl group may be substituted with two substituents wherein one substituent is at the para-position and the other at the ortho- position. An electron-donating group is herein defined as a group that releases electrons into a reaction center and as such stabilizes electron deficient carbocatjons. Preferably, the electron-donating group has a Hammett σp-constant of less than -0.14.
Examples for suitable electron-donating groups are methyl (σp = -0.14), t-butyl (σp = - 0.15) and methoxy (σp = -0.28). The values for σp are taken from J. March, Advanced Organic Chemistry, 4th Ed., page 280 (Table 9.4), 1992. Preferred electron-donating groups include linear or branched Ci - C6 alkyl groups, cyclic C3 - C6 alkyl groups, linear or branched Ci - C6 alkoxy groups, cyclic C3 - C6 alkoxy groups, linear or branched Ci - C6 alkylthio groups, cyclic C3 - C6 alkylthio groups and OH. More preferred electron-donating groups are linear or branched Ci - C6 alkyl groups, cyclic C3 - C6 alkyl groups, linear or branched Ci - C6 alkoxy groups and cyclic C3 - C6 alkoxy groups. Even more preferred electron-donating groups are linear or branched Ci - C6 alkoxy groups and cyclic C3 - C6 alkoxy groups. Yet even more preferred electron-donating groups are linear or branched Ci - C6 alkoxy groups, even yet more preferably linear or branched C1 - C4 alkoxy groups. Most preferably, the electron- donating group is methoxy. If the phenyl or benzyl group has more than one substituent, their combined electron-donating capability is preferably equivalent to a Hammett σp-constant of less than -0.14. It is well known to the person skilled in the art which combinations of substituents provide such an electron-donating capability.
Preferred protecting groups are ortho-methoxyphenyl, para- methoxyphenyl (PMP), ortho-hydroxyphenyl, para-hydroxyphenyl and para- methoxybenzyl. The most preferred protecting group is the p-methoxyphenyl-group.
The protected amine may be derived from the protecting of any N-atoms for which protection is known. Typically, the N-atom of a secondary or tertiary amine group is protected, and may now be deprotected by the process according to the invention. Conversion of protected imines may result in protected amines, that may also be deprotected by a process according to the invention.
In the framework of this invention deprotection is defined as removing the protecting group from the N-atom.
In Scheme I an example of a typical deprotection reaction has been shown. With [O] is meant the oxidant.
- A -
Scheme 1
The process according to the invention may be suitably applied to effect deprotection of any protected amine compound. Preferred compounds to be deprotected by the process according to the invention are for example compounds according to formula 1.
R4 = H, or a (substituted) alkyl, (substituted) cycloalkyl, (substituted) alkenyl, (substituted) alkynyl or (substituted) aryl group
R1, R2 and R3 are each independently H or (substituted) alkyl, (substituted) cycloalkyl, (substituted) alkenyl, (substituted) alkynyl or (substituted) aryl groups or carboxylic acid groups or salts thereof, carboxylic esters, carboxylic thioesters or carboxamides. provided that at least two out of R1, R2 and R3 are not H and provided that not more than two groups chosen from R1, R2 and R3 are carboxylic acid groups or salts thereof, carboxylic esters, carboxylic thioesters or carboxamides.
R4 can also be a protecting group, which is the same or different from the PG group. In case R4 is the same PG then the removal of that group may take place simultaneously with the removal of the PG-group. Upon deprotection, a compound according to formula I is obtained, but with the one or two protecting groups replaced by H-atoms.
In case the protected amine contains an unprotected OH-group at the β-position, such as shown in formula 2, submission to PG removal by an oxidative enzyme of the present invention may result in occurrence of side reactions due to (partial) cleavage of the C-C bond of the 1 ,2-amino-alcohol moiety.
Formula 2
In formula 2, R2 and R4 are as defined above in formula 1 and R5 is H or a (substituted) alkyl, (substituted) cycloalkyl, (substituted) alkenyl, (substituted) alkynyl or (substituted) aryl group. These side reactions may be partially or fully avoided by first protecting the OH-group at the β-position, then performing the amine deprotection with an oxidative enzyme of the present invention, and finally removing the OH-protecting group. For instance, it is envisaged that the OH-group can be protected with a benzyl group, using benzylbromide and sodium hydride, followed by amine deprotection with a laccase enzyme - with limited or no side reactions due to cleavage of the C-C bond of the 1 ,2-amino-alcohol moiety - and finally removal of the benzyl group using hydrogenation with hydrogen and Pd/C under acidic conditions, giving the desired deprotected 1 ,2-amino-alcohol in high yield. The OH-group can, for example, also be protected with a tert-butyl-diphenylsilyl group, using tert-butyl-diphenylsilylchloride in the presence of imidazole, followed by amine deprotection with a laccase enzyme - with limited or no side reactions due to cleavage of the C-C bond of the 1 ,2-amino- alcohol moiety - and finally removal of the tert-butyl-diphenylsilyl group by HF/pyridine, giving the desired deprotected 1 ,2-amino-alcohol in high yield.
Preferably, ,the method according to the invention is carried out with a protected amine compound not comprising an OH-gropu at the β-position.
The cycloalkyl groups in protected amines according to formula 1 or 2 may optionally have one or more unsaturated, exocyclic or endocyclic, carbon carbon bonds.
If substituted, the alkyl, cycloalkyl, alkenyl, alkynyl, and aryl groups that may be present in protected amines according to formula 1 or 2 may be substituted with optionally protected, functional groups comprising one or more heteroatoms such as for example oxygen, sulphur and nitrogen. Additionally, the alkyl, alkenyl and alkynyl groups may be interrupted by one or more heteroatoms such as
oxygen, sulphur and nitrogen, whereas the cycloalkyl and aryl groups may comprise within their ring system one or more heteroatoms such as oxygen, sulphur and nitrogen.
The alkyl, alkenyl, and alkynyl groups that may be present in R1, R2, R3 , R4 and R5 each independently typically comprise 1-30 C atoms. Preferably, at least one of R1, R2, R3' R4 and R5 comprises 1-6 C atoms, more preferably, all R1, R2, R3, R4 and R5 comprise between 1-6 C atoms if they are an alkyl, alkenyl or alkynyl group.
The cycloalkyl or aryl group that may be present in R1, R2, R3 ,R4 and R5 typically comprises 1-30 C atoms. Preferably, at least one of R1, R2, R3 ,R4 and R5 comprises 3-6 C atoms, more preferably, all R1, R2, R3 R4 and R5 comprise between 3- 6 C atoms if they are a cycloalkyl or aryl group.
Any compound obtained by the process according to the invention may subsequently be isolated by known techniques, or may be further converted without being isolated. In the framework of this invention, an oxidative enzyme is defined as an enzyme which catalyses an oxidation reaction of a substrate, in this case the substrate being the compound to be deprotected, in the presence of an oxidant.
Since the process according to the invention involves the transfer of electrons, the enzyme used in the process according to the invention must be able to catalyse oxidations, more preferably, it is able to catalyse one electron oxidations.
An enzyme suitable for the process according to the invention typically comprises a protein part and one or more metal atoms, whereby the metal atom or atoms must be able to exist in at least two different oxidation states.
All enzymes known capable of transferring electrons may in principle be suitable to be used in the process according to the invention. Now that it has been found that an oxidative enzyme may be used to effect deprotection of protected amine groups, a person skilled in the art will be able to identify suitable enzymes for the process according to the invention, and suitable oxidants to use with the enzymes. The experiments as described in the experimental and examples section of this text, and the assay described therein may be suitable used for the screening of enzymes.
Preferably, the enzyme used in the process according to the invention is an oxidative enzyme chosen from enzyme class (E. C.) 1.10.3 or an oxidative enzyme of the enzyme class E. C. 1.1 1.
Most preferably, laccases (E. C. 1.10.3.2) are used in the process according to the invention. Even more preferably, laccases are used for the removal of
an optionally substituted aryl or optionally substituted arylmethyl protecting group. Most preferably, laccases are used for the removal of a PMP-protecting group.
Laccases are multi-copper oxidases found in several trees and fungi, catalyzing the oxidation of various types of substances with concomitant reduction of oxygen to water, avoiding the formation of the hazardous hydrogen peroxide. Laccases are commercially available from e.g. Jϋlich Fine Chemicals and Sigma-Aldrich.
Suitable laccases that are commercially available are disclosed in the Examples section.
A mixture of enzymes may also be used in the process according to the invention.
The enzyme or enzymes used in the process according to the invention may be used in any form known, for example a such, as part of whole cells, or in immobilized form, for example as beads, etc.
The process according to the invention is carried out in the presence of an oxidising agent, also sometimes referred to as oxidant. In principle, any oxidising agent that is capable of oxidizing the protected amine may be used in the process according to the invention.
Each oxidative enzyme needs a suitable oxidant. Suitable oxidants for a particular enzyme are known to the skilled person, and can be found e.g. through the Enzyme Classification system.
For oxidative enzymes from the class E. C. 1.10.3, oxygen is a suitable oxidant. Typically, if oxygen is the oxidant used in the process according to the invention, the oxygen used in the process according to the invention is the oxygen dissolved in the reaction mixture. When no care is taken to exclude air from the reaction mixture, there will always be some oxygen present in the reaction mixture. However, it is also possible to create a higher concentration of oxygen in the reaction mixture, by contacting the reaction mixture with a gas containing oxygen in a higher concentration than air, or even with pure oxygen, for example by bubbling an oxygen containing gas or pure oxygen through the reaction mixture. For enzymes chosen from the class E. C. 1.1 1 , peroxides, for example
H2O2 may be suitably added as the oxidant.
Since the exact reaction mechanism is not known, it is also unknown exactly which species are involved in the deprotection process according to the invention. Thus, the process according to the invention also relates to a process for the
deprotection of protected amine compounds according to the invention wherein the oxidant is formed in situ.
The preparation of protected amines is known to a person skilled in the art. The protected amine compounds can, for instance, be prepared through reductive amination of the corresponding ketones with p-anisidine as, for example, described by A. Pelter, R. Rosser, S. Mills, J. Chem. Soc, Perkin Trans. 1 1984, 4,
717-720. Alternatively, the protected amine compounds can be prepared via asymmetric Mannich reactions as, for instance, described by B. List et al, Angew.
Chem. Int. Ed, 2005, 44, 7424, B. List, Ace. Chem. Res. 2004, 37, 548-557, CF. Barbas III et al, Adv. Synth. Catal. 2004, 346, 1131-1 140 and CF. Barbas III et al,
J. Org. Chem. 2003, 68, 9624-9634.
Typically, at least some water is present in the process according to the invention. However, since enzymes are known that are active in an organic solvent, it may also be possible to carry out the process according to the invention in a reaction mixture not comprising any water.
Preferably, the process is carried out in a solution that comprises water. More preferably, at least one equivalent of water is present relative to the amine compound to be deprotected.
In a typical embodiment, the process according to the invention is carried out in a mixture of solvents, typically a mixture of water and one or more other solvents, also referred to as co-solvents. Any solvent may be used as a co-solvent.
Thus, the co-solvent may have a miscibility with water that ranges from immiscible to poorly miscible to well miscible. Accordingly, the process according to the invention may be carried out as a one phase process or as a two or more phase process. It is known that enzymes may be deactivated by organic solvents.
Thus, the process according to the invention is preferably carried out in the presence of water and a co-solvent that results in no or little deactivation during reaction.
Preferably, the process according to the invention is carried out in the presence of water and a solvent that together with water forms a homogeneous mixture. More preferably, the process is carried out in a mixture of water and a polar organic solvent, such as for example dimethylsulfoxide, methanol, acetonitrile, sulfolane, N,N-dimethylformamide, N-methyl-pyrrolidinone. The polar organic solvent may be protic or aprotic.
The amount of co-solvent may vary between wide ranges. Depending on the protected amine compound to be deprotected in the process according to the
invention, it may be advantageous to increase the amount of protected amine compound that may be dissolved by increasing the amount of co-solvent. However, for solvents that cause deactivation of the enzyme used, it is preferred to use as little as possible. Therefore, the preferred amount of co-solvent depends on the protected amine compound used and the enzyme used. Typically, the amount of co-solvent used is more than 5 vol%, and typically the amount of co-solvent used is less than 50 vol%, relative to the total volume of the reaction mixture.
A person skilled in the art will be able to identify the optimum reaction conditions for each reaction with a given enzyme. Another factor that has influence on the process according to the invention is the pH, specifically the activity of the enzyme is pH dependent. The optimum pH for a process according to the invention can be determined by routine experimentation by a person skilled in the art. The pH may vary between wide limits, for example between 0 and 1 1. Typically, the optimum pH is lower than 9, preferably lower than 7, more preferably, lower than 6. Typically, the optimum pH is higher than 2, more preferably, higher than 2.5.
In the examples it has been demonstated that deprotection of Λ/-PMP protected benzylic amines involving laccases, is most effective at a pH below 4.
At too low pH values, enzymes may be deactivated. The process according to the invention wherein laccase is used as the oxidative enzyme, is therefore typically carried out at a pH higher than 3. To keep the pH at a desired value, a buffer may be used. In principle, any known buffer may be used. Preferably, the buffer is inert with respect to the compound to be deprotected and the (free) amine obtained after deprotection has taken place, the enzyme and the oxidant used. Thus, in this context inert is defined as not reactive towards the reactant and desired product under the conditions under which the process according to the invention is carried out.
Known buffer systems suitable for use in enzymatic reactions are phosphate buffers, acetate buffers and citric acid buffers. Depending on the desired pH and the type of enzyme used, a skilled person can select the most suitable buffer system.
The pressure at which the process according to the invention may be carried out is not critical and may vary between wide limits, for example 0.01 bar and 100 bar.
Typically, the process according to the invention is carried out under atmospheric pressure.
Th e temperature at which the process according to the invention may be carried out is not critical, as long as it is not so high that the enzyme is deactivated. Typically, the process according to the invention is carried out at a temperature of 0°C or higher, preferably at a temperature of 10°C or higher, more preferably at a temperature of 15 °C or higher, even more preferably at a temperature of 20°C or higher, and most preferably at a temperature of 25°C or higher.
The process according to the invention is typically carried out at a temperature of 80°C or lower, preferably 70°C or lower, more preferably 60°C or lower, even more preferably 50°C or lower, and most preferably 40°C or lower. The amount of enzyme relative to the protected amine compound is not critical, and will be different for each enzyme. Typically, the amount of enzyme added is based on a compromise between enzyme cost and reaction time. Many factors influence the activity of an enzyme, for example temperature, pH, type of solvent etc, thus, and hence, the amount added will also be influenced by those factors. A person skilled I the art will be able to determine for each enzyme which amounts are effective amounts, i.e. which amounts result in the desired conversion under the chosen reaction conditions.
The suitable amount of oxidant relative to the protected amine compound can easily be determined by a person skilled in the art. For instance, if oxygen is used as the oxidant typically a large excess of oxidant is used for instance by contacting the reaction mixture with air or another gas containing oxygen. If hydrogen peroxide is used as the oxidant, the amount of oxidant is typically higher than 0.8 equivalent and preferably higher than 0.9 equivalent relative to the protected amine compound since full or almost full deprotection of the protected amine compound is usually desirable. If hydrogen peroxide is used as the oxidant, the amount of oxidant is also typically lower than 3 equivalent and preferably lower than 1.5 equivalent relative to the protected amine since a too high concentration of hydrogen peroxide may deactivate the enzyme.
In an embodiment, the process according to the invention is carried out in the presence of a mediator. A mediator is defined as an organic molecule acting as electron shuttle between the enzyme and the substrate. The use of a mediator may result in an improved conversion and/or selectivity relative to the same process according to the invention carried out in the absence of a mediator. Use of a mediator may also result in expanding the substrate scope of a given enzyme. In some cases,
the enzymatic activity of a certain enzyme towards a certain protected amine compound only becomes easily detectable in the presence of a mediator.
It is assumed that mechanistically, the mediator is oxidized by the enzyme (e.g. laccase) and then converts the substrate into the oxidized form. The reduced mediator can subsequently be reoxidized by the enzyme so that both the enzyme and the mediator can be used in a catalytic fashion using e.g. oxygen as the stoichiometric oxidant (thereby producing water as the by-product).
In the examples it is shown that the presence of a mediator in the process according to the invention results in a higher conversion in a shorter time than when the same reaction is carried out in the absence of a mediator. Moreover, it is shown that mediators often result in widening the substrate scope of a particular enzyme. For the process according to the invention, the substrates are the protected amine compounds.
All known mediators may be used in the process according to the invention. Examples of mediators can be found in literature on enzymes. Suitable mediators for the process according to the invention are for example compounds comprising an N-hydroxy functional group, and other mediators known for laccases.
For laccases, suitable mediators have been described by D.
Rochefort et al., Green. Chem., 2004, 6, 14-24. Although the paper deals with the use of laccases in the paper pulp industry, the mediators described are also suitable for the process according to the invention.
Some examples of mediators for laccases are 2,2'- azinobis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS), violuric acid (VLA), 1 ,5- tetramethylpiperidine-N-oxide (TEMPO), hydroxybenzatriazole (HOBT), and syringaldehyde, as depicted in Figure 1 , and N-hydroxyacetanilide (NHA).
If a mediator is used, the suitable amount of mediator may vary between wide limits, for example 0.001 - 10 molar equivalents relative to the protected amine compound. However, the mediator typically only needs relatively small quantities to be effective. Therefore, when a mediator is used, the process of the invention is preferably carried out in the presence of 0.01-0.2 molar equivalents of mediator relative to the protected amine compound.
The invention also relates to a process for the deprotection of protected amines resulting from all possible combinations of claim 1 with one or more preferred embodiments, preferred protected amines, preferred reaction conditions, including preferred enzymes, oxidising agents or mediators, hitherto not explicitly
disclosed as a combination. The invention also relates to the use of an oxidative enzyme for the deprotection of a protected amine compound as claimed in Claim 15, also in all possible combinations of one or more preferred features for the enzyme, the protected amine compound, the oxidising agent and any other applicable preferred feartures as disclosed herein.
The resulting deprotected amines can be used as a pharmaceutical, nutraceutical, food or feed ingedrient or agrochemical or as an intermediate in the process thereto. For instance, the resulting deprotected amines can be converted to heterocyclic compounds.
EXAMPLES General
Reagents and solvents were obtained at commercial quality and used without further purification. IR spectra were recorded on a Thermo Mattson IR300 equipped with a Harrick split pea ATR unit. 1H NMR and 13C NMR spectra were recorded at 300 (75) or 400 (100) MHz. HRMS (ESI) spectra were recorded on a JEOL AccuTOF. Commercially available laccase T from Trametes versicolor was purchased from Jϋlich Fine Chemicals in two batches as a light brown lyophilized powder. The activity of the first batch (used in the experiments as shown in Table 1 , entries 1-32) was 24 U/mg (using syringaldazin). The activity of the second batch (used in the experiments as shown in Table 1 , entries 33-60, Tables 2 and 3) was 1.2 U/mg (using syringaldazin). Laccase AB from Agaricus bisporus was commercially available from Jϋlich Fine Chemicals as a brown lyophilized powder (activity 7.9 U/mg (using catechol)). Amine 12 is commercially available. Amines 10 and 13 were prepared through reductive amination of the corresponding ketones as described in A. Pelter, R. Rosser, S. Mills, J. Chem. Soc, Perkin Trans. 1 1984, 4, 717-20. Amines 1 and 14 were prepared according to known procedures as described in Y. Hayashi, W. Tsuboi, I. Ashimine, T. Urushima, M. Shoji, K. Sakai, Angew. Chem. Int. Ed. 2003, 42, 3677- 3680. Amine 15 was prepared by non-stereoselective reduction of the ketone function of Mannich adduct 15a using NaBH4. Recorded spectra of 1 (see: W. Notz, F. Tanaka, S.-l. Watanabe, N. S. Chowdari, J. M. Turner, R. Thayumanavan, C. F. Barbas, J. Org. Chem. 2003, 68, 9624-9634, 10, (see: T. Itoh, K. Nagata, M. Miyazaki, H. Ishikawa, A. Kurihara, A. Ohsawa, Tetrahedron 2004, 60, 6649-6655) and 12-14 (see: W. Notz, F. Tanaka, S.-l. Watanabe, N. S. Chowdari, J. M. Turner,
R. Thayumanavan, C. F. Barbas, J. Org. Chem. 2003, 68, 9624-9634 and T. Itoh, K. Nagata, M. Miyazaki, H. Ishikawa, A. Kurihara, A. Ohsawa, Tetrahedron 2004, 60, 6649-6655) were in accordance with those reported in the literature. The procedures for the preparation of amines 15, 16 and 16a are described below.
(2S,3S)-3-((4-Methoxyphenyl)(methyl)amino)-2-methyl-3-(4-nitrophenyl)propan-1-ol (15)
To a solution of 14 (3.0 g, 9.5 mmol) in MeCN (50 ml_), was added K2CO3 (2.6 g, 19 mmol) and MeI (6.7 g, 47 mmol). The resulting suspension was stirred for 16 h at 40 0C and subsequently filtered off. The filtrate was concentrated in vacuo and the resulting residue was taken up in CH2Cb (50 ml_). The organic solution was washed with water (50 ml.) and brine (50 ml_), dried (MgSO4) and concentrated in vacuo. The crude product was purified through flash chromatography (30% EtOAc/n- heptane) giving product 15 as a red syrup in quantitative yield. 1H-NMR (CDCI3, 300 MHz) δ 1.20 (d, J = 6.6 Hz, 3H), 1.89 (bs, 1 H), 2.58 (s, 3H), 3.38 (dd, J = 4.9, 10.6 Hz, 1 H), 3.58 (dd, J = 3.7, 10.7 Hz, 1 H), 3.75 (s, 3H), 6.80 (m, 4H), 7.26 (d, J = 8.1 Hz, 2H), 8.11 (d, J = 8.4 Hz, 2 H); 13C-NMR (CDCI3, 75 MHz) δ 14.8, 34.1 , 35.7, 55.6, 67.7, 114.5, 118.7, 123.3, 128.8, 144.7, 145.1 , 147.0, 153.4; IR v (cm"1): 3387, 2933, 1509, 1344, 1243, 1034, 811 ; HRMS (ESI+) calcd for Ci8H23N2O4 (M+) 331.1658, found 331.1670.
(S)-4-(3,4-Dimethoxyphenyl)-4-(4-methoxyphenylamino)-2-butanone (16a).
To a stirred solution of 3,4-dimethoxybenzaldehyde (10.1 g, 60.9 mmol) and p-anisidine (7.43g, 60.3 mmol) in DMSO/acetone (255ml, 1 :4) was added L-proline (1.47g, 12.75 mmol). The resulting suspension was stirred at room
temperature for 21 h, quenched with saturated NH4CI(aq) (55 mL) and extracted with EtOAc (4 x 50 ml). The combined organic fractions were dried (Na2SO4) and concentrated. Precipitation occurred and the formed precipitate was filtered off, giving product 16a as an off-white solid (8.0 g, 39%). 1H-NMR (CDCI3, 400 MHz) δ 2.1 1 (s, 3H), 2.89 (d, J = 6.4 Hz, 2H), 3.70 (s, 3H), 3.85 (s, 3H), 4.69 (t, J = 6.8 Hz, 1 H), 6.52 (d, J = 8.8 Hz, 2H), 6.70 (d, J = 8.8 Hz, 2H), 6.81 (d, J = 8.8 Hz, 1 H), 6.89 (d, J = 6.0 Hz, 2H); 13C-NMR (CDCI3, 75 MHz) δ 30.8, 51.4, 55.2, 55.7, 55.9, 109.5, 11 1.3, 11 1.7, 115.4, 118.2, 135.3, 141.1 , 148.1 , 149.2, 152.4; IR v (cm"1): 3480, 1703, 1512, 1256, 1233, 1140, 1025, 813; HRMS (ESI+) calcd for Ci9H23NO4 (M+) 329.1627, found 329.1617.
(4S)-4-(3,4-Dimethoxyphenyl)-4-(4-methoxyphenylamino)-2-butanol (16).
To a cooled stirred solution of 16a (1.08 g, 3.29 mmol) in MeOH (50 mL) was carefully added NaBH4 (1.46 g, 38.6 mmol). The resulting suspension was stirred for 1 h and acidified with aqueous 5 M HCI to pH 1 and extracted with CH2CI2 (3 x 20 mL). 5 M NaOH was added until pH 11 was reached and the solution was extracted with EtOAc (4 x 30 mL). The combined organic fractions were dried (Na2SO4) and concentrated to give product 16 as an off-white solid (1.06 g, 97%, dr 2:1 ). 1H- NMR (CDCI3, 400 MHz) δ 1.25 and 1.23 (d, J = 6.2 Hz, 3H), 1.88 (m, 2H), 3.70 and 3.69 (s, 3H), 3.85 (m, 6H), 4.03 (m, 1 H), 4.50 and 4.39 (dd, J = 8.8; 7.4 Hz, 1 H), 6.55 (m, 2H), 6.68 (m, 2H), 6.83 (m, 3H); 13C-NMR (CDCI3, 75 MHz) δ 23.8, 24.4, 46.8, 55.7, 55.9, 56.2, 65.4, 68.0, 11 1.2, 11407, 1 15.1 , 1 16.6, 118.2, 136.4, 140.9, 147.4, 148.7, 151.7, 152.1 ; IR v (cm"1): 3494, 3203, 1511 , 1234, 1 138, 1019, 812; HRMS (ESI+) calcd for Ci9H25NNaO4 (M+Na+) 354.1654, found 354.1667.
2-Methoxy-N-(4-phenylbutan-2-yl)aniline (22)
To a solution of acetic acid (1.91 ml_, 33.3 mmol), 4-phenylbutan-2- one (5.00 ml_, 33.3 mmol) and o-anisidine (3.76 ml_, 33.3 mmol) in 250 mL dichloromethane was added sodium triacetoxyborohydride (9.89 g, 46.6 mmol). The mixture was stirred for 7 days and quenched with 250 mL of a saturated aqueous solution of NaHCOs. After layer separation, the organic layer was dried (Na2SO4) and concentrated in vacuo. The residue was purified by flash column chromatography (ethylacetate/n-heptane 1/20). The combined fractions were concentrated in vacuo and the residue was taken up in 50 mL n-heptane and extracted with 4 x 100 mL 1 M aqueous hydrochloric acid. The combined aqueous layers were brought to pH 12 using a 5 M aqueous potassium hydroxide solution and extracted with 3 x 100 mL dichloromethane. The combined organic layers were dried (Na2SO4) and concentrated in vacuo, yielding the desired product 22 as a colorless oil (2.2 g, 8.6 mmol, 26% yield). 1H-NMR (CDCI3, 300 MHz) δ 1.24 (d, J = 6.0 Hz, 3H), 1.74-1.98 (m, 2H), 2.74 (t, J = 7.8 Hz, 2H), 3.40-3.60 (m, 1 H), 3.85 (s, 3H), 4.00-4.20 (m, 1 H), 6.51-6.87 (m, 4H), 7.19-7.31 (m, 5H). 13C-NMR (CDCI3, 75 MHz) δ 21.2, 32.8, 39.1 , 47.9, 55.8, 109.9, 110.5, 116.1 , 121.6, 126.1 , 128.7, 128.8, 137.8, 142.4, 147.1.
2-(4-Phenylbutan-2-ylamino)phenol hydrochloric acid (23)
To a solution of acetic acid (1.91 mL, 33.3 mmol), 4-phenylbutan-2- one (5.00 mL, 33.3 mmol) and 2-aminophenol (3.64 g, 33.3 mmol) in 250 mL dichloromethane was added sodium triacetoxyborohydride (9.89 g, 46.6 mmol). The mixture was stirred for 3 days and quenched with 250 mL of a 1 M aqueous solution of hydrochloric acid. The resulting white precipitate was filtered off and redissolved in 25 mL methanol. Diisopropylether (300 mL) was added and the resulting white solid was filtered off and dried. Yield of 23: 7.1 g (25.6 mmol, 77% yield).
1H-NMR (CD3OD, 300 MHz) δ 1.41 (d, J = 6.3 Hz, 3H), 1.40-2.22 (m, 2H), 2.65-3.38 (m, 2H), 3.60-3.80 (m, 1 H), 6.99-7.41 (m, 9H). 13C-NfVtR (CD3OD, 75 MHz) δ 17.5, 33.3, 36.6, 59.7, 118,7, 122.0, 123,1, 126.9, 128,2, 130.1, 130,4, 133.1, 142,5, 153.2.
4-(4-Phenylbutan-2-ylamino)phenol (24)
To a solution of acetic acid (1.91 ml_, 33.3 mmol), 4-phenylbutan-2- one (5.00 ml_, 33.3 mmol, and 2-aminophenol (3.64 g, 33.3 mmol) in 250 ml_ dichloromethane was added sodium triacetoxyborohydride (9.89 g, 46.6 mmol). The mixture was stirred for 3 days and quenched with 250 ml. of a 1 M aqueous solution of hydrochloric acid. The solution was concentrated in vacuo until full removal of the dichloromethane. The resulting aqueous phase was then washed with 3 x 250 ml. n- heptane and subsequently made slightly alkaline (pH 8) by the addition of an aqueous 5 M solution of potassium hydroxide. The resulting aqueous solution was extracted with 250 ml. dichloromethane. The combined organic phase was dried (Na2SO4) and concentrated in vacuo. The crude residue was recrystallized twice from diisopropyl ether to obtain the desired compound 24 as a white solid (2.5 g, 10 mmol, 31% yield). The resulting spectral data were in accordance with values reported in the literature (T. Suwa, E. Sugiyama, I. Shibata, A. Baba, Synthesis, 2000, 6, 789-800).
(2S.3SV3-(4-MethoxybenzylaminoV2-methyl-3-(4-nitrophenvnpropan-1-ol (25)
To a solution of compound 19. HCI (0.419 g, 1.698 mmol) in 100 ml_ acetonitrile was added p-methoxybenzylchloride (0.254 ml_, 1.868 mmol), LiI (0.023 g,
0.170 mmol) and NaHCO3 (0.713 g, 8.49 mmol). The mixture was heated to reflux, stirred over night and poured out into a mixture of 200 ml. dichloromethane and 200 ml. saturated aqueous NaHCO3 solution. The mixture was concentrated in vacuo until full removal of the acetonitrile and dichloromethane. The resulting aqueous solution was extracted with 200 ml. dichloromethane. The organic phase was dried with Na2SO4 and concentrated in vacuo. The residue was purified by flash column chromatography, which gave product 25 as a colorless oil (0.309 g, 0.935 mmol). 1H-NMR (CDCI3, 300 MHz) δ 0.79 (d, J = 7.2 Hz, 3H), 2.09-2.18 (m, 1 H), 3.47-3.68 (m, 2 x 2H), 3.80 (s, 3H), 4.05 (d, J = 3.9 Hz, 1 H), 6.83-6.88 (m, 2H), 7.11-7.16 (m, 2H), 7.48-7.52 (m, 2H), 8.22-8.27 (m, 2H). 13C-NMR (CDCI3, 75 MHz) δ 12.8, 39.8, 51.5, 55.7, 66.4, 66.9, 1 14.4, 123.9, 129.1 , 131.3, 147.7, 148.3.
EXAMPLE 1
Deprotection of PMP-protected amine 1 using laccase T and Laccase AB in the absence of a mediator.
An HPLC assay to screen laccases by monitoring the conversion of starting material, i.e. the Λ/-PMP protected amine into the desired free amine, was developed. As a benchmark substrate, PMP-protected 1 ,3-amino alcohol 1 was used. First, 4 mg of laccase T (from Trametes versicolor) was added to 1 mL of a solution of 1 (1.0 mg) in an acetonitrile/aqueous buffer (pH 5.0) mixture. Addition of the laccase immediately altered the color of the reaction mixture from colorless to purple, indicating enzymatic activity. Subjection of the crude reaction mixture to the HPLC assay clearly demonstrated the formation of the free amine 3 and benzoquinone (4, Table 1 ). After this first result, the influence of various reaction conditions was studied by carrying out experiments in which co-solvent and pH were varied. Two commercially available laccases were employed without modification, in lyophilized form, namely laccase T and laccase AB (from Agaricus bisporus).
rt=room temperature (about 20°C)
Table 1a. Screening of reaction parameters entry laccase solvent vol% buffer PH t (h) conversion to 3 (%)a
1 T MeCN 60 24 32
2 T MeCN 70 5 24 46
3 T MeCN 80 24 46
4 T MeCN 90 24 73
5 T THF 60 24 27
6 T THF 70 24 47
7 T THF 80 24 79
8 T THF 90 5 24 51
9 T EtOAc 60 24 O
10 T EtOAc 70 24 12
11 T EtOAc 80 24 21
12 T EtOAc 90 Il C CNN
O O O O O O O O O O O O O Oiiiiiiiiii iiii 24 58
13 T toluene 60 24 1 1
14 T toluene 70 24 23
15 T toluene 80 24 44
16 T toluene 90 24 44
17 AB MeCN 80 1 18 5
18 AB MeCN 80 18 2
19 AB MeCN 80 3 18 4
20 AB MeCN 80 4 18 24
21 AB MeCN 80 5 18 25
22 AB MeCN 80 6 18 20
23 AB MeCN 80 7 18 15
24 AB MeCN 80 8.5 18 13
25 T MeCN 80 1 18 O
26 T MeCN 80 18 8
27 T MeCN 80 3 18 82
28 T MeCN 80 4 18 74
29 T MeCN 80 5 18 61
30 T MeCN 80 6 18 37
Table 1 b. Screening of reaction parameters entry laccase solvent vol% buffer PH t (h) conversion to
3(%)a
31 T MeCN 80 7 18 23
32 T MeCN 80 8.5 18 0
33 T MeCN 60 3 4 42
34 T MeCN 70 3 4 68
35 T MeCN 80 3 4 77
36 T MeCN 90 3 4 79
37 T MeCN 60 3 20 53
38 T MeCN 70 3 20 76
39 T MeCN 80 3 20 80
40 T MeCN 90 3 20 85
41 T THF 60 3 4 19
42 T THF 70 3 4 48
43 T THF 80 3 4 58
44 T THF 90 3 4 70
45 T THF 60 3 20 31
46 T THF 70 3 20 72
47 T THF 80 3 20 75
48 T THF 90 3 20 82
49 T DMSO 60 3 18 84
50 T DMSO 70 3 18 85
51 T DMSO 80 3 18 89
52 T DMSO 90 3 18 91
53 T MeOH 60 3 18 75
54 T MeOH 70 3 18 78
55 T MeOH 80 3 18 82
56 T MeOH 90 3 18 87
57 T MTBE 60 3 18 47
58 T MTBE 70 3 18 64
59 T MTBE 80 3 18 72
60 T MTBE 90 3 18 87
Conditions: laccase T or AB (4 mg) was added to a solution of 1 (1 mg) in the buffer/solvent mixture (1 ml_), rt. a Conversions were determined using HPLC (Inertsil ODS-3 column) on crude samples taken from the reaction mixture.
Thus, a series of experiments was carried out in a phosphate buffer (50 mM, pH 5)/co-solvent mixture, thereby varying the co-solvent. The conversions of substrate 1 into the free amine 3, as determined by HPLC, are depicted in Table 1a. (entries 1-16). These results show that the laccase-mediated PMP deprotection proceeds faster in homogeneous systems (e.g. MeCN, THF, MeOH, DMSO), but that the use of a biphasic system (e.g. EtOAc, toluene, MTBE) is also applicable. Additionally, it must be noted that higher amounts of co-solvent, although rendering the substrate more soluble, significantly decrease the overall reaction rate through enzyme deactivation. Evaluation of the pH dependence of the reaction in a buffer mixture/MeCN (4:1 ) using both laccases T and AB (entries 17-32). clearly showed that the conversions increased with lower pH values, albeit that too acidic conditions (pH < 3) led to enzyme deactivation.
A series of industrially viable solvents was evaluated in varying ratios with the buffer solution (entries 33-60). No real solvent limitations were identified in these experiments, although the use of acetonitrile and DMSO gave slightly better results. In addition, there was no clear difference between mono- and biphasic systems both giving high conversions to the desired product.
Subjection of protected amino alcohol 1 to laccase AB gave a maximum conversion of 25% (phosphate buffer pH 5/MeCN 4:1 , entry 21 ).
EXAMPLE Il Deprotection of PMP-protected amines 1 and 10 using laccase T and Laccase AB in the presence of a mediator.
The influence of various mediators on the process according to the invention was studied.
The reaction of experiment I (entry 21 ), was repeated in the presence of 1 equivalent ABTS (based on the protected amine compound). The conversion to 3 increased to 84% (instead of 25% in entry 1-21 ), 18 h, rt, 1 equiv of ABTS).
For each mediator, a blank reaction without enzyme was also conducted. In all cases there was no conversion of the protected amine substrate, except for TEMPO, which showed a percentage of conversions equivalent to the mol% of TEMPO added (e.g. 10mol% TEMPO added resulted in 10% conversion).
In addition to increasing the conversion, it was also found that the substrate scope could be extended by using mediators.. Introduction of any of the mediators 5-9 led to high conversions to the corresponding amine 11 (Table 2).
Table 2. Influence of mediators. entry mediator conversion (18 h) conversion (48 h)
1 5 43 87
2 6 50 88
3 7 53 80
4 8 30 75
5 9 71 83
EXAMPLE Deprotection of various protected amine compounds and isolation of the deprotected amines
Procedure for the laccase-mediated PMP-deprotection of 1.
To a solution of 0.92 mmol of a PMP-protected amine (in case of 1 , 250 mg) in THF (40 ml.) and phosphate buffer (160 ml_, pH 3, 50 mM) was added laccase T (120 mg) and if desired ABTS (10 mol %). The resulting suspension was stirred for 20 h at room temperature, acidified to pH 1 with 5 N HCI and filtrated over Celite. The filtrate was washed with CH2CI2 (3 x 100 ml_). The resulting aqueous phase was subsequently brought to pH 10.5 via addition of 5 N NaOH and extracted with EtOAc (4 x 75 ml_). The combined organic fractions were dried (Na2SO4) and brought to pH 1 via addition of HCI/EtOAc, and concentrated under reduced pressure to afford the deprotected amine as the HCI-salt (when 1 was used, the salt was 2. HCI (124 mg, 67%) which was a white solid.
This procedure was conducted for substrate 1 as well as substrates 10, 13-16 with laccases T and AB (Table 3). It may be noted that subjection of PMP- protected benzylamine 12 to these enzymes did not produce benzylamine (17) itself.
Instead, formation of benzaldehyde was observed, suggesting oxidation at the benzylic position, followed by hydrolysis of the resulting imine. In all other cases, however, the corresponding free amines 11 , 18-21 were isolated after workup in reasonable to good yields and excellent purity.
Table 3. Preparative deprotections using laccase T and AB.5 entry W-PMP amine laccase product (yield)c
PMP^ χ\ N Ph H2N^^Ph H
1
3 13 T 18 (31%)
4* AB 18 (56%)
PMP
HNT NH2
HO^^Ξ^^Ph HO^^r^^Ph
Me Me
5 1 T 2 (67%)
6* 1 AB 2 (71%)
11 16 T 21 (34%)
12* 16 AB 21 (41%)
^PMP NH2 HN
Ph^^^ Ηe
Ph^^^Me
13* 10 T 11 (30%)
14* 10 AB 11 (47%) a Conditions: PMP-protected amine (0.92 mol), laccase (120 mg), THF/buffer mixture (1 :4, pH 3, 200 ml_), rt. b Reaction conducted in the presence of ABTS (10 mol%). c Products were isolated as HCI-salts.
(2S,3S)-3-(4-Methoxyphenylamino)-2-methyl-3-phenylpropan-1 -ol hydrochloride (2)
OR [α]D 20 -24.3 (c 0.18, MeOH); 1H-NMR (400 MHz, D2O) δ 1.12 (d, J = 6.9 Hz, 3H), 2.36 (m, 1 H), 3.37 (dd, J = 5.4, 11.4 Hz, 1 H), 3.42 (dd, J = 5.4,1 1.4 Hz, 1 H), 4.33 (d, J = 8.2 Hz, 1 H), 7.50 (m, 5H); 13C-NMR (75 MHz, D2O) δ 12.3, 37.9, 57.8, 62.6, 126.9, 128.7, 128.7, 134.6; IR v (cm"1): 3330, 3112, 2975, 2871 , 1489, 1473, 1026, 706, 558; HRMS (ESI+) calcd for Ci0H16NO 166.1232, found, 166.1248; Anal. Calcd. for Ci0H16CINO: C, 59.55; H, 8.00, N, 6.94. Found: C, 58.05; H, 7.87; N, 6.84
4-Phenylbutan-2-amine hydrochloride (1 1 )
Spectral data were in accordance with those reported in the literature, (see: M. Kitamura, S. Chiba, K. Narasaka, Bull. Chem. Soc. Jpn. 2003, 76, 1063- 1070).
1-Phenylethanamine hydrochloride (18)
1H-NMR (400 MHz, D2O) δ 1.65 (d, J = 6.9 Hz, 3H), 4.55 (q, J = 6.2 Hz, 1 H), 7.49 (m, 5H); 13C-NMR (I OO MHz, D2O) δ 19.5, 51.2, 126.7, 129.4, 129.4, 137.9; IR v (cm"1): 2972, 2879, 1609, 1513, 1084, 1032, 763, 696, 537; HRMS (ESI+) calcd for C8Hi2N (M+) 122.0970, found 122.0981.
(2S,3S)-3-Amino-2-methyl-3-(4-nitrophenyl)propan-1 -ol hydrochloride (19)
1H-NMR (H2O, 300 MHz), δ 1.12 (d, J = 6.8 Hz, 3H), 2.41 (m, 1 H), 3.42 (d, J = 5.2 Hz, 1 H), 4.53 (d, J = 7.7 Hz, 2H), 7.69 (d, J = 8.5 Hz, 1 H), 8.37 (d, J ■
8.5Hz, 1H); 13C-NMR (H2O, 75 MHz), δ 12.1,38.0, 57.1,62.4, 123.7, 128.1, 142.0, 147.5; IR v (crrT1): 3671, 2985, 2900, 1406, 1393, 1250, 1066, 1055, 891, 669; HRMS (ESI+) calcd for C10H15N2O3211.1083, found 211.1086; Anal. Calcd. for C11H15CIN2O3: C, 48.69; H, 6.13; N, 11.36. Found: C, 48.72; H, 6.12; N, 11.14.
(2S,3S)-2-Methyl-3-(methylamino)-3-(4-nitrophenyl)propan-1-ol hydrochloride (20)
1H-NMR (400 MHz, D2O) δ 1.04 (d, J = 6.8 Hz, 3H), 2.55 (m, 1 H), 2.59(s, 3H), 3.37 (dd, J=7.1, 11.4Hz, 1H), 3.45 (dd, J = 4.9, 11.5Hz, 1H), 4.44 (d, J = 6.5 Hz, 1 H), 7.71 (d, J = 8.6 Hz, 2H), 8.39 (d, J = 8.4 Hz, 2H); 13C-NMR (75 MHz, D2O) 612.4,31.3,36.8,62.3,66.1, 123.9, 129.3, 138.6, 147.8; IR v (cm"1): 3369, 2965, 1606, 1521, 1461, 1348, 1035,857, 701; HRMS (ESI+) calcd for C11H17N12O2
225.1239, found 225.1251; Anal. Calcd for C11H18CINO: C, 50.68; H, 6.57; N, 10.74. Found: C, 49.97; H, 6.65, N, 10.34.
(S)-4-Amino-4-(3,4-dimethoxyphenyl)-2-butanol hydrochloride (21 )
1H-NMR(CD3OD, 400 MHz) δ 1.19 and 1.22 (d, J = 6.2 Hz, 3H), 2.05 (m, 2H), 3.68 and 3.81 (m, 1 H), 4.48 (m, 1 H), 4.86 (s, 6H), 7.45 (m, 3H)
13C-NMR (CD3OD, 75 MHz) δ 23.5, 24.5, 54.0, 55.6, 64.9, 78.7, 79.1, 79.5, 127.7, 128.1, 129.6, 130.1; IR v (cm"1): 3190, 2943, 2908, 1524,939,696; HRMS (ESI+) calcd for C12H20NO3226.1443, found 226.1432.
EXAMPLE IV:
Deprotection of 2-methoxy-N-(4-phenylbutan-2-yl)aniline (22)
Compound 22 (0.200 g, 0.783 mmol) was dissolved in 20 ml. acetonitrile/80 mL aqueous phosphate buffer 100 mM pH 3. To the resulting solution was added 100 mg laccase T. The mixture was stirred for 5.5 hours, acidified with 5 M aqueous hydrochloric acid to pH 1.0 and subsequently washed with 3 x 75 ml. dichloromethane. The aqueous layer was brought to pH 1 1 with 5 M aqueous potassium hydroxide and extracted with 3 x 75 ml. ethyl acetate (while maintaining the pH at 11 by the addition of extra potassium hydroxide solution). The combined organic layers were dried, acidified with 2 ml. of a saturated solution of hydrochloric acid in ethylacetate and concentrated. The residue was purified with flash column chromatography (mixtures of dichloromethane/methanol). The combined organic fractions were acidified with HCI in ethylacetate and concentrated to yield product 11. HCI as an off-white solid (0.051 g, 0.28 mmol, 35 % yield).
EXAMPLE V:
Deprotection of 2-(4-phenylbutan-2-ylamino)phenol hydrochloric acid (23)
To a solution of compound 23 (0.218 g, 0.783 mmol) in 20 mL acetonitrile/80 mL aqueous phosphate buffer 100 mM pH 3 was added ABTS (0.043 mg, 0.078 mmol) and 100 mg laccase T. The mixture was stirred for 18 hours, acidified with 5 M aqueous hydrochloric acid to pH 1.0 and subsequently washed with 3 x 100 mL dichloromethane. The aqueous layer was brought to pH 11 with 5 M aqueous
potassium hydroxide and extracted with 3 x 150 mL ethylacetate (while maintaining the pH at 11 by the addition of extra potassium hydroxide solution). The combined organic layers were dried, acidified with 2 mL saturated solution of hydrochloric acid in ethylacetate and concentrated in vacuo. Product 11. HCI was obtained as an off-white solid (0.043 g, 0.232 mmol, 30% yield).
EXAMPLE VI:
Deprotection of 4-(4-phenylbutan-2-ylamino)phenol (24)
Compound 24 (0.189 g, 0.783 mmol) was dissolved in 20 mL acetonitrile/80 mL aqueous phosphate buffer 100 mM pH 3. To the resulting mixture was added 100 mg laccase T. The mixture was stirred for 19.5 hours, acidified with 5 M aqueous hydrochloric acid to pH 1.0 and subsequently washed with 3 x 75 mL dichloromethane. The aqueous layer was brought to pH 1 1 with 5 M aqueous potassium hydroxide and extracted with 3 x 75 mL ethylacetate (while maintaining the pH 11 by the addition of extra potassium hydroxide solution). The combined organic phase was dried (Na2SO4), acidified with 2 mL of a saturated solution of hydrochloric acid in ethylacetate and concentrated in vacuo. Product 11.HCI was obtained as an off-white solid (0.134 g, 0.722 mmol, 92 % yield).
EXAMPLE VII:
Deprotection of (2S,3S)-3-(4-methoxybenzylamino)-2-methyl-3-(4-nitrophenyl)propan-
1 -QI (25)
25 19.HCI To a solution of 50 mg (0.15 mmol) PMB-protected amine 25 in 50 ml. aqueous phosphate buffer (100 mM pH 3) was added 8.3 mg (0.015 mmol) ABTS followed by 50 mg laccase T. The mixture was stirred and after 20 hours, fresh laccase T (50 mg) and ABTS (8.3 mg, 0.015 mmol) were added. After an additional 24 hours of stirring, the reaction mixture was brought to pH 1 by the addition of 5 M hydrochloric acid and washed with 3 x 75 ml. dichloromethane. Subsequently, the resulting aqueous phase was brought to pH 1 1 with a 5 M aqueous solution of potassium hydroxide and extracted with 3 x 75 ml. ethylacetate (while maintaining the pH at 11 by the addition of extra potassium hydroxide solution). The combined organic phase was dried (Na2SO4), acidified with hydrochloric acid in ethylacetate and concentrated. The resulting residue was a mixture of the starting material and the desired deprotected amine as their HCI salts. The corrected yield for the product is 0.028 g (0.133 mmol, 75%).
EXAMPLE NX:
Deprotection using immobilised laccase T
14 19.HCI
To a solution of compound 14 (0.316 g, 1.0 mmol) in 40 mL tetrahydrofuran/160 mL 100 mM aqueous phosphate buffer (pH = 3) was added 200 mg CLEA laccase T (obtained from CLEA Technologies, Delft, The Netherlands). The
resulting suspension was stirred for 28 hours and washed with dichloromethane (2 x 200 ml_). The aqueous layer was brought to pH 11 with 5 M aqueous potassium hydroxide and extracted with 3 x 200 ml. ethylacetate (while maintaining the pH at 1 1 by the addition of extra potassium hydroxide solution). The combined organic layers were dried with Na2SO4, acidified with hydrochloric acid in ethyl acetate and concentrated in vacuo giving 19. HCI (0.19 g, 0.78 mmol, 78% yield).
EXAMPLE IX:
Deprotection using Horse Radish Peroxidase
14 19
A 3.5 wt% solution of H2O2 was prepared by diluting 1 ml. of an aqueous 35 wt% H2O2 solution with 9 ml. aqueous phosphate buffer (100 mM, pH 3). To a solution of 10 mg (0.032 mmol) of compound 14 in 2 ml. acetonitrile/8 ml. 100 mM aqueous phosphate buffer (pH = 3) was added 56 μl_ of the prepared H2O2 solution. To the resulting solution, 0.4 mg Horse Radish Peroxidase (obtained from Fluka,168 u/mg) was added. After 30 minutes, the reaction mixture was analyzed by HPLC, which showed full conversion of the starting material to the free amine 19. HPLC was conducted on an lnertsil ODS 3 column (150 mm length, 4.6 mm internal diameter) at a flow of 1.0 mL/min and using a UV detector at 210 and 254 nm. The eluent consisted of mixtures of solvent A (aqueous 10 mM phosphate buffer pH 3.0) and solvent B (acetonitrile). The applied gradient was as follows: t = 0-2 min: 0% B; t = 2-6 min: 0^50% B; t = 6-10 min: 50% B; t = 10-12 min: 50^70% B; t = 12-14 min: 70% B; t = 14 - 16.5 min: 70^0% B; t = 16.5-19 min: 0% B. Retention times: compound 19: 8.2 min; benzoquinone 9.2 min, compound 14: 15.3 min.
Claims
A process for the deprotection of a protected amine compound, wherein the protected amine compound which comprises a protecting group attached to the N-atom of the amine, is contacted with an oxidative enzyme and an oxidising agent that may optionally be formed in situ and wherein the protected amine compound to be deprotected is a compound according to formula 1
R4 = H, or a (substituted) alkyl, (substituted) cycloalkyl, (substituted) alkenyl, (substituted) alkynyl or (substituted) aryl group
R1, R2 and R3 are each independently H or (substituted) alkyl, (substituted) cycloalkyl, (substituted) alkenyl, (substituted) alkynyl or (substituted) aryl groups or carboxylic acid groups or salts thereof, carboxylic esters, carboxylic thioesters or carboxamides provided that at least two out of R1, R2 and R3 are not H and provided that not more than two groups chosen from R1, R2 and R3 are carboxylic acid groups or salts thereof, carboxylic esters, carboxylic thioesters or carboxamides. and wherein the protecting group is an optionally substituted aryl group or an optionally substituted arylmethyl group and wherein the enzyme is an oxidative enzyme of the enzyme class E. C. 1.10.3 or an oxidative enzyme of the enzyme class E. C. 1.11.
2. Process according to claim 1 , wherein the optionally substituted aryl or arylmethyl group is an optionally substituted C6 - Ci4 aryl or C6 - Ci4 arylmethyl group comprising one or more electron-donating groups.
3. Process according to any one of claims 1-2, wherein the protecting group is chosen from the group of ortho-methoxyphenyl, para-methoxyphenyl (PMP), ortho-hydroxyphenyl, and para-hydroxyphenyl.
4. Process according to any one of claims 1-3, wherein the protecting group is a p-methoxyphenyl-group.
5. A process according to any one of claims 1-4 wherein the enzyme is of the enzyme class E. C. 1.10.3.2.
6. Process according to any one of claims 1-5, wherein the process is carried out in a solution comprising water.
7. Process according to any one of Claims 1-6, wherein the process is carried out at a pH lower than 7.
8. Process according to any one of Claims 1-7, wherein the process is carried out at a pH lower than 5.
9. Process according to any one of Claims 1-8, wherein the process is carried out in the presence of a mediator.
10. Process according to Claim 9, wherein the process is carried out in presence of a substrate according to Formula 1 , wherein R1, R2 and R3 are all non-aryl groups.
11. Use of oxidative enzymes in a process for deprotection of a protected secondary or tertiary amine compound.
12. Use according to claim 11 , wherein the enzyme is a laccase.
13. Use according to claim 1 1 or 12, wherein the amine compound is protected with a PMP-group.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07010481 | 2007-05-25 | ||
EP07010481.5 | 2007-05-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008145620A1 true WO2008145620A1 (en) | 2008-12-04 |
Family
ID=38514153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2008/056389 WO2008145620A1 (en) | 2007-05-25 | 2008-05-23 | Process for the deprotection of aryl group protected amines employing oxidases |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008145620A1 (en) |
-
2008
- 2008-05-23 WO PCT/EP2008/056389 patent/WO2008145620A1/en active Application Filing
Non-Patent Citations (3)
Title |
---|
VERKADE, J.M.M. ET AL.: "Laccase-Mediated Deprotection of para-Methoxyphenyl (PMP)-Protected Amines", ADVANCED SYNTHESIS & CATALYSIS, vol. 349, no. 8-9, June 2007 (2007-06-01), pages 1332 - 1336, XP002452599 * |
VERKADE, J.M.M. ET AL.: "Mild and efficient deprotection of the amine protecting p-methoxyphenyl (PMP) group", TETRAHEDRON LETTERS, vol. 47, no. 46, 13 November 2006 (2006-11-13), pages 8109 - 8113, XP005703337 * |
WELLS, A. ET AL.: "Green oxidations with laccase-mediator systems", BIOCHEMICAL SOCIETY TRANSACTIONS, vol. 34, no. 2, April 2006 (2006-04-01), pages 304 - 308, XP002452598 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lange et al. | A new mild method for the synthesis of amidines | |
MX2009002746A (en) | Process for preparing biaryl substituted 4-amino-butyric acid or derivatives thereof and their use in the production of nep inhibitors. | |
EP1640361B9 (en) | Asymmetric urea compounds and process for producing asymmetric compounds by asymmetric conjugate addition reaction using the same as catalyst | |
Aye et al. | Parallel kinetic resolution of tert-butyl (RS)-3-oxy-substituted cyclopent-1-ene-carboxylates for the asymmetric synthesis of 3-oxy-substituted cispentacin and transpentacin derivatives | |
Jäger et al. | Peroxidase-induced C–N bond formation via nitroso ene and Diels–Alder reactions | |
US7659409B2 (en) | 3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same | |
JPH09255651A (en) | Production of n-methyl-n'-nitroguanidine | |
WO2008145620A1 (en) | Process for the deprotection of aryl group protected amines employing oxidases | |
KR20210002522A (en) | Enantiomeric selective biocatalytic preparation of 4-cyano-substituted 1-aminoindan and ozanimod | |
Doi et al. | Chirality transfer in palladium catalyzed reactions of allylammonium salts | |
US7427688B2 (en) | Production method of optically active diphenylalanine compounds | |
Caiazzo et al. | Synergy between chemo-and bio-catalysts in multi-step transformations | |
WO2010021093A1 (en) | Asymmetric organic catalyst | |
US5859281A (en) | Catalytic asymmetric aminohydroxylation of olefins with sulfonamides | |
US5686625A (en) | Process for the preparation of N-substituted glycine acids or glycine esters and the use of the process for indigo synthesis | |
Miyamoto et al. | CO 2-activated NaClO-5H 2 O enabled smooth oxygen transfer to iodoarene: a highly practical synthesis of iodosylarene. | |
JP4463209B2 (en) | Method for producing optically active amine compound | |
EP0801064A1 (en) | Process for the preparation of 2-(2-(4((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and their salts | |
Cai et al. | A new type of L-Tertiary leucine-derived ligand: Synthesis and application in Cu (II)-catalyzed asymmetric Henry reactions | |
CN111004141B (en) | New method for synthesizing nintedanib intermediate 2-chloro-N-methyl-N- (4-nitrophenyl) acetamide | |
WO2006066806A1 (en) | Manufacture of vitamin b6 | |
US7223859B2 (en) | Method for producing (R)-3-[4-(trifluoromethyl) phenylamino]-pentanoic acid amide derivative | |
US8334405B2 (en) | Chiral thiourea compounds and process for enantioselective reduction of ketones | |
EP1604975A1 (en) | Processes for production of (r)-3- 4-(trifluoromethyl)- phen ylamino pentanamide derivatives | |
US8026372B2 (en) | Process for the preparation of ε-alkoxycarbonyllysines and their analogues |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08759989 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08759989 Country of ref document: EP Kind code of ref document: A1 |